Эндоваскулярные методы лечения критической ишемии нижних конечностей у больных сахарным диабетом (обзор)

Литература:
1. Алгоритмы специализированной медицинской помощи больным сахарным диабетом/под ред. И. И. Дедова, М.В. Шестаковой, А. Ю. Майорова. 8-е изд. М.: УП ПРИНТ, 2017; 112 с.
2. Schaper NC, Andros G, Apelqvist J, et al. Specific guidelines for the diagnosis and treatment of peripheral arterial disease in a patient with diabetes and ulceration of the foot 2011. Diabetes Metab Res Rev 2012; 28 (1): 236-7. DOI: 10.1002/dmrr. 2252.
3. Baumann F, Engelberger RP, Willenberg T, et al. Infrapopliteal lesion morphology in patients with critical limb ischemia: implications for the development of anti-restenosis technologies. J Endovasc Ther 2013; 20 (2): 149-56. DOI: 10.1583/1545-1550-20.2.149.
4. Levis K. Multidrug tolerance of biofilms and persister cells. CurrTop Microbiol Immunol 2018; 322: 107-31.
5. Miyajima S, Shirai A, Yamamoto S. Risk factors for major amputations in diabetic foot gangrene patients. Diabetes Res Clin Pract 2016; 7 (3): 272-9.
6. Митиш В.A., Махкамова Ф.Т., Пасхалова Ю.С. и др. Фактическая стоимость комплексного хирургического лечения больных нейроишемической формой синдрома диабетической стопы. Хирургия: Журнал им. Н.И. Пирогова 2015; 4: 48-53. DOI: 10.17116/hirurgia2015448-53.
7. Оболенский B.H., Никитин В. Г., Ле-валь П.Ш. и др. Лечебно-диагностический алгоритм при синдроме диабетической стопы: стандарты и новые технологии. РМЖ: Хирургия 2012; 12: 585-98.
8. Черданцев Д. В., Николаева Л. П., Степаненко А. В., Константинов Е. П. Диабетические макроангиопатии: методы восстановления кровотока. Фундаментальные исследования 2010; 1: 95-9.
9. Tendera М, Aboyans V, et al. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC)/European Stroke Organisation. Eur Heart J 2011; 32 (22): 2851-906.
10. Boyko EJ, Seelig AD, Ahroni JH. Limb- and person-level risk factors for lower-limb amputation in the prospective Seattle diabetic foot study. Diabetes Care 2018; 41 (4): 891-8. DOI: 10.2337/dc17-2210.
11. Mohammedi K, Woodward M, Hirakawa Y, et al. Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study. Cardiovasc Diabetol 2016; 15 (1): 129. DOI: 10.1186/sl 2933-016-0446-x.
12. Althouse AD, Abbott JD, Forker AD, et al. Risk factors for incident peripheral arterial disease in type 2 diabetes: results from the Bypass Angioplasty Revascularization Investigation in type 2 Diabetes (BARI 2D). Trial Diabetes Care 2014; 37 (5): 1346-52. DOI: 10.2337/dc13-230.
13. Han E, Lee YH, Lee BW, et al. Anatomic fat depots and cardiovascular risk: a focus on the leg fat using nationwide surveys (KNHANES 2008-2011). Cardiovasc Diabetol 2017; 16 (1): 54. DOI: 10.1186/s12933-017-0536-4.
14. Malmstedt J, Karvestedt L, Swedenborg J, Brismar K. The receptor for advanced glycation end products and risk of peripheral arterial disease, amputation or death in type 2 diabetes: a population-based cohort study. Cardiovasc Diabetol 2015; 14: 93. DOI: 10.1186/s12933-015-0257-5.
15. Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vase Endovasc Surg 2007; 33 Suppl 1: S1-75. DOI: 10.1016/j. ejvs. 2006.09.024.
16. Graziani L, Silvestro A, Bertone V, et al. Vascular involvement in diabetic subjects with ischemic foot ulcer: A new morphologic categorization of disease severity. Eur J Vase Endovasc Surg 2007; 33 (4): 453-60. DOI: 10.1016/j. ejvs. 2006.11.022.
17. Abu Dabrh AM, Steffen MW, Undavalli C, et al. The natural history of untreated severe or critical limb ischemia. J Vase Surg 2015; 62 (6): 1642-51.
18. Stegemann E, Tegtmeier C, Bimpong-Buta NY, et al. Carbondioxide-aided angiography decreases contrast volume and preserves kidney function in peripheral vascular interventions. Angiology 2016; 67 (9): 875-81.
19. Willigendael EM, Teijink JA, Bartelink ML, et al. Smoking and the patency of lower extremity bypass grafts: a meta-analysis. J Vase Surg 2015; 42 (1): 67-74.
20. Ingle H, Nasim A, Bolia A, et al. Subintimal angioplasty of isolated infragenicular vessels in lower limb ischemia: long-term results. J Endovasc Ther 2002; 9: 411-6.
21. Fiordaliso F, Clerici G, Maggioni S, et al. Prospective study on microangiopathy in type 2 diabeticfoot ulcer. Diabetologia 2016; 59 (7): 1542-8. DOI: 10.1007/s00125-016-3961-0.
22. Luders F, Bunzemeier H, Engelbertz C, et al. CKD and acute and long-term outcome of patients with peripheral artery disease and critical limb ischemia. Clin J Am Soc Nephrol 2016; 11 (2): 216-22. DOI: 10.2215/CJN. 05600515.
23. Jamsen T, Manninen H, Tulla H, Matsi P. The final outcome of primary infrainguinal percutaneous transluminal angioplasty in 100 consecutive patients with chronic critical limb ischemia. J Vase Interv Radiol 2002; 13: 455-63.
24. Максимович И. В. Транслюминальная лазерная ангиопластика в лечении ишемических поражений головного мозга: автореф. дис. ... д-ра мед. наук. М., 2004; 36 с.
25. Vraux Н, Bertoncello N. Subintimal angioplasty of tibial vessel occlusions in critical limb ischaemia: a good opportunity? Eur J Vase Endovasc Surg. 2006; 32 (6): 663-7.
26. Faglia E, Clereci G, Caminity M, et al. Heel ulcer and blood flow: the importance of the angiosome concept. Int J Low Extrem Wounds 2013; 12 (3): 226-30. DOI: 10.1177/1534734613502043.
27. Sheehan P, Jones P, Caselli A, et al. Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial. Diabetes Care 2003; 26 (6): 1879-82. DOI: 10.2337/diacare. 26.6.1879.
28. Faglia E, Clereci G, Cleressi J, et al. When is a technically successful peripheral angioplasty effective in preventing above-the-ankle amputation in diabetic patients with critical limb ischemia? Diabetes Med 2007; 24 (8): 823-9. DOI: 10.1016/j. ejvs. 2006.12.027.
29. Santoro L, Ferraro PM, Flex A, et al. New semiquantitative ultrasonographic score for peripheral arterial disease assessment and its association with cardiovascular risk factors. Hypertens Res 2016; 39 (12): 868-73. DOI: 10.1038/hr. 2016.88.
30. Santoro L, Flex A, NesciA, et al. Association between peripheral arterial disease and cardiovascular risk factors: role of ultrasonography versus ankle-brachial index. Eur Rev Med Pharmacol Sci 2018; 22 (10): 3160-5.
31. Бондаренко O.H., Галстян Г. P., Дедов И. И. Особенности клинического течения критической ишемии нижних конечностей и роль эндоваскулярной рева-скуляризации у больных сахарным диабетом. Сахарный диабет 2015; 18(3): 57-69.
32. Вербовой А.Ф., Пашенцева А.В., Вербовая Н.И. Диабетическая макроангиопатия. Терапевтический архив 2019; 91 (10): 139-43). DOI: 10.26442/00403660.2019.10.000109.